KBC Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-11,300
| Closed | -$102K | – | 1336 |
|
|
2021
Q3 | $102K | Sell |
11,300
-11,300
| -50% | -$102K | ﹤0.01% | 1163 |
|
|
2021
Q2 | $270K | Buy |
22,600
+18,000
| +391% | +$215K | ﹤0.01% | 1135 |
|
|
2021
Q1 | $58K | Hold |
4,600
| – | – | ﹤0.01% | 1269 |
|
|
2020
Q4 | $395K | Hold |
4,600
| – | – | ﹤0.01% | 1225 |
|
|
2020
Q3 | $44K | Hold |
4,600
| – | – | ﹤0.01% | 1211 |
|
|
2020
Q2 | $42K | Buy |
4,600
+2,300
| +100% | +$21K | ﹤0.01% | 1250 |
|
|
2020
Q1 | $15K | Hold |
2,300
| – | – | ﹤0.01% | 1263 |
|
|
2019
Q4 | $19K | Buy |
2,300
+2,130
| +1,253% | +$17.6K | ﹤0.01% | 1456 |
|
|
2019
Q3 | $2K | Sell |
170
-1,130
| -87% | -$13.3K | ﹤0.01% | 1471 |
|
|
2019
Q2 | $14K | Hold |
1,300
| – | – | ﹤0.01% | 1429 |
|
|
2019
Q1 | $12K | Buy |
1,300
+450
| +53% | +$4.15K | ﹤0.01% | 1390 |
|
|
2018
Q4 | $10K | Hold |
850
| – | – | ﹤0.01% | 1293 |
|
|
2018
Q3 | $14K | Hold |
850
| – | – | ﹤0.01% | 1376 |
|
|
2018
Q2 | $12K | Buy |
850
+400
| +89% | +$5.65K | ﹤0.01% | 1276 |
|
|
2018
Q1 | $9K | Hold |
450
| – | – | ﹤0.01% | 1266 |
|
|
2017
Q4 | $7K | Buy |
+450
| New | +$7K | ﹤0.01% | 1252 |
|